Anti-human CD40LG monoclonal antibody, ruplizumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1036-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: BG-9588, hu5c8
target CD40LG
alias CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39
gene id Uniprot ID: P29965
host species Humanized
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

HEK293 cell line transfected with irrelevant protein (B) and human CD40L (A) were surface stained with Anti-CD40L mAb 1 ug/ml (ruplizumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

ELISA plate pre-coated by 2 ug/ml (100 uL/well) Human CD40 Ligand Protein, hFc Tag binds to Anti-CD40 Ligand (ruplizumab biosimilar) mAb in a linear range of 0.64-400 ng/ml.


PRODUCT

  • SKU

    DMS1036-100ug

  • Size

    100ug

  • Price

    $350

1